ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,558Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 1278

$786K Total Retail Price of All Prescriptions

Rank: 33 out of 1278

667 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 667 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

15% of this provider’s 667 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

4% of this provider’s 10,259 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 468 439 1 2
LISINOPRIL 450 429 2 1
LOVASTATIN 276 262 3 13
HYDROCODONE-ACETAMINOPHEN 266 227 S3 4 7
SIMVASTATIN 249 234 5 3
AMLODIPINE BESYLATE 235 214 6 5
METFORMIN HCL 225 202 7 4
ZOLPIDEM TARTRATE 220 207 8 16
OMEPRAZOLE 206 175 9 6
TAMSULOSIN HCL 176 176 10 32
METOPROLOL TARTRATE 155 145 11 9
CITALOPRAM HBR 149 143 12 22
DICLOFENAC SODIUM 141 136 13 74
ALENDRONATE SODIUM 140 116 14 18
METOPROLOL SUCCINATE 137 123 15 23
TRIAMTERENE-HCTZ 137 128 15 43
ATORVASTATIN CALCIUM 136 114 17 15
CRESTOR 134 112 18 31
FENOFIBRATE 129 113 19 47
ROPINIROLE HCL 124 124 20 127
MELOXICAM 116 104 21 57
GABAPENTIN 113 83 22 12
HYDROCHLOROTHIAZIDE 112 96 23 8
DONEPEZIL HCL 111 110 24 48
GEMFIBROZIL 99 88 25 54
GLYBURIDE 96 85 R 26 40
TRAZODONE HCL 96 73 26 38
CARVEDILOL 94 81 28 39
DIGOXIN 92 90 29 79
SPIRONOLACTONE 88 78 30 78
ATENOLOL 86 83 31 11
LOSARTAN POTASSIUM 84 74 32 19
ALLOPURINOL 83 78 33 36
TRAMADOL HCL 78 72 34 25
METOCLOPRAMIDE HCL 78 64 34 215
AZITHROMYCIN 77 69 36 37
WELCHOL 76 70 37 256
CYMBALTA 75 72 38 67
SERTRALINE HCL 74 70 39 28
SYNTHROID 73 57 40 63
POTASSIUM CHLORIDE 73 71 40 21
FUROSEMIDE 69 64 42 10
DOXYCYCLINE HYCLATE 66 62 43 123
LANTUS 65 55 44 33
WARFARIN SODIUM 63 57 45 17
PANTOPRAZOLE SODIUM 62 59 46 34
ESTRADIOL 60 46 R 47 71
VYTORIN 60 60 47 85
CIPROFLOXACIN HCL 59 50 49 53
NAMENDA 58 58 50 77
PREDNISONE 56 51 51 52
ACETAMINOPHEN-CODEINE 55 47 S3 52 98
DOXEPIN HCL 55 50 52 208
DIOVAN 55 42 52 44
PAROXETINE HCL 53 53 55 56
OXYCODONE-ACETAMINOPHEN 52 44 S2 56 29
NEXIUM 52 48 56 106
LIPITOR 52 46 56 95
PENTOXIFYLLINE 51 46 59 280
VERAPAMIL ER 50 50 60 84
PREMARIN 50 50 R 60 119
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 7, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.